ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1346	National Cancer Institute	Html	en	Adult Hodgkin Lymphoma Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of adult Hodgkin lymphoma.	German Hodgkin 0.354228 German Hodgkin Study 0.30322 Hodgkin Lymphoma Study 0.253534 Hodgkin lymphoma radiotherapy 0.254277 chemotherapy 0.295088 early-stage hodgkin 0.255794 median follow-up 0.203803 early-stage Hodgkin lymphoma 0.241288 disease 0.285786 Abstract 0.418591 Clin Oncol 0.717583 patients 0.627155	Hodgkin lymphoma patients 0.415158 breast cancer 0.396405 Hodgkin disease 0.282385 lymphoma study group 0.228528 Natl Cancer Inst 0.321967 Advanced-stage Hodgkin lymphoma 0.280187 hodgkin lymphoma 0.914677 Hodgkin Study Group 0.304882 radiation therapy 0.591494 Hodgkin lymphoma treatment 0.268627 cancer risk 0.204351 recurrent Hodgkin lymphoma 0.232858	CLICK HERE
1776	National Cancer Institute	Html	es	La nutrición en el tratamiento del cáncer (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca de las causas y el tratamiento de los problemas de nutrición que se presentan en pacientes de cáncer.	Oncology Nutrition Dietetic 0.794305 Nutrition risk screening 0.380015 Perioperative nutrition support 0.325434 August DA 0.321534 Bergerson S 0.42802 medical oncology patients 0.319644 American Cancer Society 0.354235 Malnutrition Screening Tool 0.336109 American Society 0.333545 Adult Oncology Patient 0.321746 Cancer Res 0.323371 nutrition interventions across 0.325357 Leser M 0.456946 cancer patients 0.534602 Hematol Oncol Clin 0.319076 Enteral Nutrition 0.453095 oncology patient 0.475881 Parenter Enteral Nutr 0.377081 Nutrition Risk Screening-2002 0.325017 nutrition therapy 0.376862 pacientes quizás 0.322377 Nutrition Dietetic Practice 0.754692 Medical nutrition therapy 0.368433 Subjective Global Assessment 0.322733 terapia nutricional 0.340919	surgical oncology patients 0.340122 clinical practice 0.555659 Radiation Oncology Nursing 0.334481 Care Cancer 0.324544 Academy’s Oncology Nutrition 0.372909 Dietetic Practice Group 0.607536 nutrition risk 0.383416 Modern Nutrition 0.321534 Oncology Nutrition Evidence 0.344953 Oncology Nursing Practice 0.345995 Top Clin Nutr 0.321751 Nutrition assessment 0.344971 nutrition impact symptoms 0.345866 Clin Nutr 0.326461 cancer cachexia 0.388006 Clinical Nutrition 0.351661 Clin Oncol 0.323666 nutrition support therapy 0.32555 Ledesma N 0.427589 Oncology Nursing Society 0.390831 Oncology Nutrition 0.930511 Oncology Nursing 0.416659 Patient-Generated Subjective Global 0.319243 Nutrition management 0.340043	CLICK HERE
1785	National Cancer Institute	Html	es	Adaptación al cáncer: ansiedad y sufrimiento (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca de las difíciles respuestas emocionales que se presentan en muchos de los pacientes con cáncer. Este sumario se enfoca en asuntos de la adaptación normal, alteración psicosocial y trastornos de adaptación.	adjustment disorders 0.371593 psychologic distress screening 0.379318 brief screening 0.406438 NCCN's rapid screening 0.36439 Sin sufrimiento 0.48459 psychological distress 0.370051 distress thermometer 0.532993 Cancer Therapy 0.378399 with early 0.358435 National Comprehensive Cancer 0.924903 Cancer Network Distress 0.416524 self-rating depression scale 0.589802 major depression 0.374428 Jacobsen PB 0.439029 Cancer Center 0.427766 Manual Diagnóstico 0.368702 mood states 0.377645 Natl Cancer Inst 0.393821 trastornos mentales 0.667498 Comprehensive Cancer Network 0.926182 rapid screening 0.44139 with cancer 0.88971 psychologic distress 0.551057 Pain Symptom Manage 0.380417 Hegel MT 0.363843	Akechi T 0.365541 Zung Self-Rating Depression 0.495839 Cancer anxiety 0.395937 American Psychiatric Association 0.655757 hospital anxiety 0.404002 Memorial Sloan-Kettering Cancer 0.384863 with newly 0.361717 mammography among screening 0.361533 Oxford University 0.368144 Johns Hopkins Cancer 0.382693 Patient With Cancer 0.418527 New York 0.365014 Community Cancer Care 0.386652 bone marrow transplant 0.361659 Brief Symptom Inventory 0.536917 newly diagnosed breast 0.450645 Clin Oncol 0.474801 Collins ED 0.360494 Kornblith AB 0.373648 depression scale 0.783205 Trask PC 0.363008 newly diagnosed 0.546482 sufrimiento extremo 0.559882 Holland JC 0.426093	CLICK HERE
1875	National Cancer Institute	Html	es	Tratamiento del linfoma relacionado con el sida (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del linfoma relacionado con el sida.	aids-related non-hodgkin lymphomas 0.608138 non-hodgkin's lymphomas 0.666621 prognostic factors 0.350902 HIV-associated Hodgkin 0.399104 Spina M 0.351065 linfoma hodgkin 0.348723 Epstein-Barr virus 0.393918 atypical burkitt lymphoma 0.351153 large b-cell lymphoma 0.344814 HIV-related lymphoma 0.343107 immunodeficiency virus 0.402901 highly active 0.512378 human immunodeficiency virus-associated 0.403779 Burkitt lymphoma 0.387609 immunodeficiency virus-associated non-Hodgkin 0.342734 AIDS patients with 0.376046 Dunleavy K 0.344239 Natl Cancer Inst 0.464946 active antiretroviral therapy 0.726916 central nervous system 0.649203 human immunodeficiency virus-related 0.374511 HIV-infected patients with 0.343338 immunodeficiency syndrome-related lymphoma 0.354213 lymphoma treated with 0.43581 patients with 0.924942	patients with primary 0.375652 chemotherapy with 0.357715 human immunodeficiency 0.754154 patients with aids-related 0.424038 oral t-cell lymphoma 0.346331 acquired immunodeficiency syndrome-related 0.357324 lymphoma is dramatically 0.348699 immunodeficiency virus-related lymphoma 0.359105 acquired immunodeficiency 0.378848 aids-related lymphoma 0.736141 treatment with 0.389583 primary central nervous 0.521797 Intern Med 0.353617 Clin Oncol 0.792214 sistema nervioso central 0.421872 systemic aids-related non-hodgkin 0.367456 non-hodgkin lymphoma 0.744829 Hodgkin lymphoma treated 0.362251 study with 0.356196 hiv-associated lymphomas 0.544837 primary effusion lymphoma 0.456053 nervous system lymphoma 0.736571 células b 0.35592 AIDS-related primary lymphoma 0.361221	CLICK HERE
1988	National Cancer Institute	Html	es	Tratamiento de los tumores de hipófisis (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de los tumores de hipófisis.	glándula tiroides 0.529036 radiocirugía estereotáctica 0.552565 elabora hormonas 0.687272 cráneo.ampliar craneotomía 0.524586 siguientes aspectos 0.527045 retraso delcrecimiento 0.526689 cuerpo.ampliar anatomía 0.527477 funcionante elabora hormonas 0.57895 Más transpiración 0.522716 Adenomas hipofisarios benignos 0.552964 hormona cortisol 0.560608 cortisol ayuda 0.538031 siguientes tamaños 0.525264 hipófisis causa efectos 0.614286 National Cancer Institute 0.521245 tumores benignos 0.568335 sustancia llamada gadolinio 0.54378	estrías púrpuras 0.526556 siguientes riesgos 0.516532 endocrina múltiple tipo 0.548329 Instituto Nacional 0.536226 hueso esfenoides.ampliar cirugía 0.545911 PDQ Tratamiento 0.543327 alta potencia 0.518465 siguientes problemas 0.529819 siguientes signos 0.538015 suficientes hormonas 0.551735 sistema nervioso central 0.9835 Physician Data Query 0.575155 tratamiento don radiación 0.552351 siguientes enfermedades 0.530576 siguientes operaciones 0.524705 tumores funcionantes 0.567454 cáncer.Las siguientes pruebas 0.55136	CLICK HERE
2031	National Cancer Institute	Html	es	Tratamiento de la enfermedad trofoblástica de la gestación (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de la enfermedad trofoblástica de la gestación.	Glándula tiroidea hiperactiva 0.562015 maligna.Molas invasoras 0.545444 siguientes procedimientos 0.560552 estadio iv 0.537226 siguientes aspectos 0.546924 tumores trofoblásticos epitelioides 0.805684 molas invasoras 0.909175 vía oral 0.5248 rayos x 0.529833 enlace drugs approved 0.541637 gonadotropina coriónica huma 0.544512 Gestational Trophoblastic Disease 0.542392 National Cancer Institute 0.526399 ecografía transvaginal 0.535921 siguientes riesgos 0.522487 Instituto Nacional 0.591908 áreas anormales.ampliar examen 0.55209	cuerpo elabora hormona 0.593063 PDQ Tratamiento 0.555876 gestación causa efectos 0.735263 molares.ampliar dilatación 0.527024 partes distantes 0.78863 siguientes factores 0.551671 Physician Data Query 0.592879 estadio i 0.537379 último panel 0.524777 estadio iii 0.537123 término enfermedad 0.57453 siguientes operaciones 0.536826 histerectomía laparoscópica total.Ampliar 0.550873 siguientes enlaces 0.525533 histerectomía abdominal 0.531238 siguientes pruebas 0.60278	CLICK HERE
3564	National Cancer Institute	Html	en	The NCI Intramural Research Program	The intramural research program supports projects conducted by scientists located at NCI.	intramural cancer research 0.718907 intramural research program 0.874728 public health issues 0.586317 IRP researchers 0.99482 clinical disciplines 0.535611 basic research discovery 0.633697 cancer initiation 0.556039 NCI offices 0.598153 private sector partners 0.575197 long-term cohort studies 0.573663 NCI intramural research 0.823709 extramural institutions 0.555913 future research 0.545095 clinical trials 0.610273 sophisticated statistical approaches 0.591904 outstanding scientific credentials 0.582191 rare cancers 0.616347 outstanding research 0.546529 clinical IRP researchers 0.677303 extramural investigators 0.808101 basic scientific research 0.670523 cervical cancer 0.590079 traditional funding mechanisms 0.574359 Early-stage clinical trials 0.595705	intramural researchers 0.664665 Cancer Epidemiology 0.564756 population-based research 0.591379 various reasons—to fund 0.579705 National Cancer Program 0.628399 cancer prevention 0.546859 noninfectious virus-like particles 0.5887 relatively little funding 0.573973 cancer research 0.783668 academic institutions 0.606037 high-reward research 0.541951 NCI IRP 0.623146 CCR’s John 0.543838 NIH Clinical Center 0.948229 public health needs 0.603453 Intramural research projects 0.689496 research program complement 0.627977 basic cancer research 0.675487 research resources 0.556851 CCR researcher Ira 0.613887 NCI components 0.59726 CCR colleagues 0.538611 cancer risk 0.53862 federal government investigators 0.655439	CLICK HERE
3569	National Cancer Institute	Html	en	Lung-MAP: Master Protocol for Squamous Cell Lung Cancer	A collection of material about the Lung-MAP study, which will examine treatment outcomes for patients with squamous cell lung cancer assigned to different targeted drugs based on the results of genomic tumor profiling.	Cancer Master Protocol 0.761779 cancer-related genes 0.485085 similar large cancer 0.550307 unique public-private collaboration 0.635287 biomarker-driven clinical trial 0.547514 genomic screening 0.486006 immune system fight 0.473995 lung cancer 0.958963 Cancer Therapy Evaluation 0.548913 National Clinical Trials 0.624831 genomic profile 0.494996 clinical testing 0.479299 U.S. Food 0.476247 advanced squamous cell 0.974568 Squamous cell carcinoma 0.611382 drug nivolumab 0.477374 typical clinical trial 0.556218 patients 0.598987 new investigational treatment 0.557707 single biomarker 0.478327 standard approach 0.479591 current standard 0.486778 drug developers 0.47659 screening tests 0.477882	Drug Administration 0.477451 cancer cells 0.493264 phase II/III trial 0.55125 squamous cell lung 0.99877 Clinical Trials Network 0.627666 precision medicine trial 0.62764 website provides information 0.530495 Cancer Research 0.488908 treatment arm 0.481046 Lung Cancer Master 0.790983 different experimental treatments 0.535025 genomic profiling 0.496642 targeted therapy tests 0.532918 genomic alterations 0.502152 genetic alteration 0.474138 trial arm 0.505132 investigational treatments 0.488936 genetic changes 0.47769 Lung-MAP Launches 0.474509 cell lung cancer 0.935701 treatment options 0.487036 greater likelihood 0.474643 biologics R&D arm 0.540299 new targeted therapies 0.528849	CLICK HERE
17172	National Cancer Institute	Html	es	Hongos medicinales (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso de los hongos medicinales como tratamiento para las personas con cáncer.	tumores colorrectales benignos 0.523017 Centro Nacional 0.437112 New Hampshire Avenue 0.425865 Coriolus versicolor 0.603005 Drug Administration 0.41603 NCI Best Case 0.44366 hongo tejado 0.42735 hongos trametes 0.464694 tipo ganoderma 0.427842 datos bibliográficos pubmed 0.427701 siguientes preguntas 0.418216 células t 0.427868 hongos cola 0.470178 siguientes riesgos 0.422485 Instituto Nacional 0.543935 Ganoderma lucidum 0.60047 Salud Complementaria 0.454998 Visuals Online 0.419017	sumario hongos 0.465605 polisacárido -K 0.427899 complementarias revisa 0.427138 Physician Data Query 0.509146 Estados Unidos 0.759861 estadio iii 0.424138 libre uso 0.423898 Lentinus edodes 0.430494 Asia Oriental 0.421328 página manejo 0.417832 ¿El tratamiento 0.429283 inmunitarias llamadas linfocitos 0.447603 ¿Los beneficios 0.416234 juntos cam 0.415492 Series Program 0.416063 medicina complementaria 0.932021 Trametes versicolor 0.613189 tipo cola 0.441661	CLICK HERE
17279	National Cancer Institute	Html	es	Planes para atender un cáncer avanzado	Una planificación cuidadosa reducirá el peso que enfrentará su familia más adelante. La planificación puede incluir aspectos económicos y legales, pero como verá, también puede ser una forma de celebrar su vida y de darle significado.	tensiones. Algunas personas 0.876955		CLICK HERE